RXST RxSight, Inc.

NASDAQ
$5.01

RxSight, Inc. (RXST) is expected to report earnings on February 2, 2027, after the market close. The consensus earnings estimate is $0.28 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +21.9% since its last earnings release on November 3, 2026.

RxSight Beat Consensus Estimates
Tuesday, November 3, 2026 · 4:05 PM ET
Earnings Date
4th Quarter, Dec 2026
Feb 2
Tuesday · 4:05 PM ET
Earnings Whisper
-
vs $0.28
Rev est $58.06M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $4.95

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About RxSight, Inc.

RxSight, Inc. is a commercial-stage medical technology company dedicated to improving the vision of patients following cataract surgery.

Sector

Healthcare

Industry

Medical Instruments/Supply

Held By 1 ETFs, by dollar flow

Charts powered in part by Lightweight Charts™ by TradingView.